Hologic, Inc. (HOLX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

ResMed, Inc.

STERIS Plc (Ireland)

Agilent Technologies, Inc.

West Pharmaceutical Services, Inc.

Hologic, Inc.

IDEXX Laboratories, Inc.

Align Technology, Inc.

GE Healthcare Technologies, Inc.

Zimmer Biomet Holdings, Inc.

Mettler-Toledo International, Inc.

Baxter International, Inc.

Why is Hologic, Inc. ?

High Management Efficiency with a high ROE of 26.13%

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.44 times

Poor long term growth as Net Sales has grown by an annual rate of 4.15% over the last 5 years

Flat results in Jun 25

INVENTORY TURNOVER RATIO(HY) Lowest at 2.58 times

With ROE of 17.54%, it has a fair valuation with a 3.71 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -6.08%, its profits have risen by 7.8% ; the PEG ratio of the company is 1.7

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -6.08% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Hologic, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hologic, Inc. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Hologic, Inc.

-3.37%

0.04

29.76%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.15%

EBIT Growth (5y)

7.51%

EBIT to Interest (avg)

14.25

Debt to EBITDA (avg)

0.44

Net Debt to Equity (avg)

0.19

Sales to Capital Employed (avg)

0.53

Tax Ratio

18.29%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

26.30%

ROE (avg)

26.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.71

EV to EBIT

18.89

EV to EBITDA

14.41

EV to Capital Employed

3.27

EV to Sales

4.48

PEG Ratio

1.65

Dividend Yield

ROCE (Latest)

17.31%

ROE (Latest)

17.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

DEBTORS TURNOVER RATIO(HY)

Highest at 6.53 times

INTEREST COVERAGE RATIO(Q)

Highest at 1,145.67

RAW MATERIAL COST(Y)

Fallen by 0.29% (YoY

NET SALES(Q)

Highest at USD 1,023.8 MM

-2What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.58 times

Here's what is working for Hologic, Inc.

Interest Coverage Ratio

Highest at 1,145.67

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Debtors Turnover Ratio

Highest at 6.53 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Highest at USD 1,023.8 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost

Fallen by 0.29% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hologic, Inc.

Inventory Turnover Ratio

Lowest at 2.58 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio